Clinical Trial

A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MRG007 combination therapy in patients with advanced colorectal cancer.
Trial Details
NCT Number NCT07737600
Lead Sponsor Lepu Biopharma Co., Ltd.
Conditions Advanced Colorectal Cancer
Enrollment 316 participants
Start Date 2026-08
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-04